Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-26T14:57:53.379Z Has data issue: false hasContentIssue false

P.069 Respiratory dysfunction and sleep disordered breathing in children with Myasthenia Gravis

Published online by Cambridge University Press:  27 June 2018

HF Qashqari
Affiliation:
(Toronto)
I Narang
Affiliation:
(Toronto)
H Katzberg
Affiliation:
(Toronto)
K Vezina
Affiliation:
(Toronto)
A Khayat
Affiliation:
(Toronto)
N Chrestian
Affiliation:
(Toronto)
J Vajsar
Affiliation:
(Toronto)
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Background: Myasthenia Gravis ( MG) is an autoimmune disease that affects the neuromuscular junction. It typically presents with fluctuating muscle weakness which can affect respiratory muscles. Data about the prevalence of sleep disordered breathing in children with MG and the benefits of non-invasive ventilation outside the setting of MG crisis has not been studied so far. Methods: Eleven children between 3 and 18 years old with confirmed MG were recruited from the The Hospital for Sick Children Neuromuscular clinic in a prospective observational study. Informed consent was obtained and patients underwent PFTs, MIP/MEP, SNIP, FVC and standard polysomnography testing’s. Results: In our study, we found that 2/11 children had abnormal Apnea Hypopnea index (AHI) and were diagnosed with obstructive sleep apnea (OSA). One of them has juvenile ocular MG with mild to moderate OSA and the second child has congenital MG with mild OSA. CPAP therapy was initiated for both patients. Conclusions: In our cohort, obstructive sleep apnea rate was significantly higher in children with MG than the known prevalence in general pediatric population ( 18% vs 2-3% ). Early diagnosis and management of OSA can have great impact on children’s health and quality of life. A larger study is needed to validate our findings.

Type
POSTER PRESENTATIONS
Copyright
© The Canadian Journal of Neurological Sciences Inc. 2018